Nanoviricides Stock Performance
| NNVC Stock | USD 1.15 0.03 2.54% |
The company secures a Beta (Market Risk) of 0.71, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, NanoViricides' returns are expected to increase less than the market. However, during the bear market, the loss of holding NanoViricides is expected to be smaller as well. At this point, NanoViricides has a negative expected return of -0.26%. Please make sure to verify NanoViricides' potential upside, as well as the relationship between the daily balance of power and market facilitation index , to decide if NanoViricides performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days NanoViricides has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in February 2026. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders. ...more
Last Split Factor 1:20 | Dividend Date 2019-09-24 | Last Split Date 2019-09-24 |
1 | NanoViricides Announces Closing of 6 Million Registered Direct Offering and Concurrent Private Placement Priced at the Market Close | 11/12/2025 |
2 | How NanoViricides Inc. stock compares with tech leaders - Market Growth Review Community Consensus Trade Signals - Newser | 12/04/2025 |
3 | Treating Measles Infection Nanoviricides CEO Dr Anil Diwan Interviewed by Steve Darling from Proactive - Savannah Morning News | 12/09/2025 |
4 | Is DaVita Stock Underperforming the Dow - Barchart.com | 12/15/2025 |
5 | Fluence Energy Stock Trades Up, Here Is Why - Barchart.com | 12/18/2025 |
6 | Why RXO Stock Is Down Today - Barchart.com | 12/29/2025 |
7 | Is NanoViricides Inc stock oversold or undervalued - Market Growth Review Reliable Entry Point Trade Alerts - moha.gov.vn | 01/07/2026 |
8 | Market Recap Can NanoViricides Inc NV3P stock sustain institutional flows - Inflation Watch Stock Portfolio Risk Control - moha.gov.vn | 01/12/2026 |
9 | NanoViricides Announces Closing of 6 Million Registered Direct Offering and Concurrent Private Placement Priced at the Market Close - hattiesburgamerican.com | 01/23/2026 |
| Begin Period Cash Flow | 4.8 M | |
| Total Cashflows From Investing Activities | -57 K |
NanoViricides | Build AI portfolio with NanoViricides Stock |
NanoViricides Relative Risk vs. Return Landscape
If you would invest 153.00 in NanoViricides on October 28, 2025 and sell it today you would lose (38.00) from holding NanoViricides or give up 24.84% of portfolio value over 90 days. NanoViricides is currently does not generate positive expected returns and assumes 6.4977% risk (volatility on return distribution) over the 90 days horizon. In different words, 58% of stocks are less volatile than NanoViricides, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
NanoViricides Target Price Odds to finish over Current Price
The tendency of NanoViricides Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 1.15 | 90 days | 1.15 | about 79.77 |
Based on a normal probability distribution, the odds of NanoViricides to move above the current price in 90 days from now is about 79.77 (This NanoViricides probability density function shows the probability of NanoViricides Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days NanoViricides has a beta of 0.71. This indicates as returns on the market go up, NanoViricides average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding NanoViricides will be expected to be much smaller as well. Additionally NanoViricides has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. NanoViricides Price Density |
| Price |
Predictive Modules for NanoViricides
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as NanoViricides. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of NanoViricides' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
NanoViricides Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. NanoViricides is not an exception. The market had few large corrections towards the NanoViricides' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold NanoViricides, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of NanoViricides within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.29 | |
β | Beta against Dow Jones | 0.71 | |
σ | Overall volatility | 0.24 | |
Ir | Information ratio | -0.05 |
NanoViricides Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of NanoViricides for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for NanoViricides can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| NanoViricides generated a negative expected return over the last 90 days | |
| NanoViricides has high historical volatility and very poor performance | |
| NanoViricides may become a speculative penny stock | |
| NanoViricides has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (9.47 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| NanoViricides currently holds about 14.07 M in cash with (8.48 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.21, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| NanoViricides has a frail financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: NanoViricides Announces Closing of 6 Million Registered Direct Offering and Concurrent Private Placement Priced at the Market Close - hattiesburgamerican.com |
NanoViricides Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of NanoViricides Stock often depends not only on the future outlook of the current and potential NanoViricides' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. NanoViricides' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 15.1 M | |
| Cash And Short Term Investments | 1.6 M |
NanoViricides Fundamentals Growth
NanoViricides Stock prices reflect investors' perceptions of the future prospects and financial health of NanoViricides, and NanoViricides fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on NanoViricides Stock performance.
| Return On Equity | -0.94 | ||||
| Return On Asset | -0.51 | ||||
| Current Valuation | 23.68 M | ||||
| Shares Outstanding | 21.57 M | ||||
| Price To Earning | (6.02) X | ||||
| Price To Book | 3.46 X | ||||
| EBITDA | (8.72 M) | ||||
| Net Income | (9.47 M) | ||||
| Cash And Equivalents | 14.07 M | ||||
| Cash Per Share | 1.21 X | ||||
| Total Debt | 1.31 M | ||||
| Debt To Equity | 0 % | ||||
| Current Ratio | 34.92 X | ||||
| Book Value Per Share | 0.41 X | ||||
| Cash Flow From Operations | (8.48 M) | ||||
| Earnings Per Share | (0.50) X | ||||
| Market Capitalization | 24.8 M | ||||
| Total Asset | 8.82 M | ||||
| Retained Earnings | (148.84 M) | ||||
| Working Capital | 364.19 K | ||||
| Current Asset | 24.38 M | ||||
| Current Liabilities | 6.74 M | ||||
About NanoViricides Performance
By analyzing NanoViricides' fundamental ratios, stakeholders can gain valuable insights into NanoViricides' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if NanoViricides has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if NanoViricides has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (1.00) | (1.05) | |
| Return On Capital Employed | (1.15) | (1.21) | |
| Return On Assets | (0.97) | (1.01) | |
| Return On Equity | (1.13) | (1.19) |
Things to note about NanoViricides performance evaluation
Checking the ongoing alerts about NanoViricides for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for NanoViricides help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| NanoViricides generated a negative expected return over the last 90 days | |
| NanoViricides has high historical volatility and very poor performance | |
| NanoViricides may become a speculative penny stock | |
| NanoViricides has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (9.47 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| NanoViricides currently holds about 14.07 M in cash with (8.48 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.21, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| NanoViricides has a frail financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: NanoViricides Announces Closing of 6 Million Registered Direct Offering and Concurrent Private Placement Priced at the Market Close - hattiesburgamerican.com |
- Analyzing NanoViricides' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether NanoViricides' stock is overvalued or undervalued compared to its peers.
- Examining NanoViricides' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating NanoViricides' management team can have a significant impact on its success or failure. Reviewing the track record and experience of NanoViricides' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of NanoViricides' stock. These opinions can provide insight into NanoViricides' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for NanoViricides Stock analysis
When running NanoViricides' price analysis, check to measure NanoViricides' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NanoViricides is operating at the current time. Most of NanoViricides' value examination focuses on studying past and present price action to predict the probability of NanoViricides' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NanoViricides' price. Additionally, you may evaluate how the addition of NanoViricides to your portfolios can decrease your overall portfolio volatility.
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |